Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 112Leukemia, Lymphocytic, Chronic, B-Cell 111Leukemia 102Myelodysplastic Syndromes 101Precursor Cell Lymphoblastic Leukemia-Lymphoma 80Lymphoma 77Lymphoma, Non-Hodgkin 73Multiple Myeloma 69Hodgkin Disease 67Lymphoma, Follicular 55Lymphoma, Mantle-Cell 52Leukemia, Myelogenous, Chronic, BCR-ABL Positive 51Myeloproliferative Disorders 50Congenital Abnormalities 47Lymphoma, Large B-Cell, Diffuse 46Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myeloid, Accelerated Phase 43Leukemia, Myeloid, Chronic-Phase 42Burkitt Lymphoma 41Leukemia, Myelomonocytic, Chronic 40Blast Crisis 33Primary Myelofibrosis 32Lymphoma, Large-Cell, Immunoblastic 30Waldenstrom Macroglobulinemia 29Neoplasms, Plasma Cell 29Melanoma 29Anemia, Refractory, with Excess of Blasts 29Recurrence 27Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Myelodysplastic-Myeloproliferative Diseases 24

Interventions

Cisplatin 8Etoposide 6Paclitaxel 5Ifosfamide 4Sunitinib 3Oxaliplatin 3Cyclophosphamide 3Brentuximab Vedotin 3tremelimumab 2pembrolizumab 2etoposide phosphate 2durvalumab 2Sirolimus 2Gemcitabine 2Everolimus 2Epirubicin 2Dexamethasone 2Carboplatin 2Bleomycin 2Bevacizumab 2tozuleristide 1rolapitant 1ribociclib 1pegfilgrastim 1pazopanib 1olaparib 1fosaprepitant 1fludarabine phosphate 1fludarabine 1cabozantinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms, Germ Cell and Embryonal × fludarabine phosphate × Clear all
NCT05634785 2026-01-09

CD30 CAR for CD30+ NSGCT

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
2 enrolled

Nonseminomatous germ cell tumor, Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡